Solventum Co. (NYSE:SOLV) Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Solventum Co. (NYSE:SOLV - Free Report) by 26.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 230,435 shares of the company's stock after buying an additional 47,547 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.13% of Solventum worth $15,467,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Worldquant Millennium Advisors LLC boosted its stake in shares of Solventum by 373.6% in the third quarter. Worldquant Millennium Advisors LLC now owns 47,665 shares of the company's stock worth $3,323,000 after buying an additional 37,600 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in Solventum by 24.8% in the fourth quarter. Harbor Capital Advisors Inc. now owns 46,965 shares of the company's stock valued at $3,103,000 after buying an additional 9,333 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Solventum by 37.4% in the third quarter. The Manufacturers Life Insurance Company now owns 117,853 shares of the company's stock worth $8,217,000 after acquiring an additional 32,051 shares during the period. State Street Corp boosted its stake in shares of Solventum by 3.1% during the 3rd quarter. State Street Corp now owns 6,107,550 shares of the company's stock worth $425,818,000 after acquiring an additional 185,938 shares in the last quarter. Finally, Forsta AP Fonden acquired a new stake in shares of Solventum during the 4th quarter valued at about $1,876,000.

Remove Ads

Solventum Trading Up 0.3 %

NYSE:SOLV traded up $0.20 during trading hours on Wednesday, hitting $76.54. The company had a trading volume of 1,368,507 shares, compared to its average volume of 1,392,568. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $85.92. The company has a market cap of $13.24 billion and a P/E ratio of 27.83. The company has a 50-day moving average of $75.60 and a 200 day moving average of $71.97. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Analyst Ratings Changes

SOLV has been the topic of a number of recent analyst reports. Mizuho increased their price target on Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. The Goldman Sachs Group lifted their price target on shares of Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research note on Monday, March 3rd. Morgan Stanley upped their price objective on shares of Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research report on Wednesday, March 5th. Wells Fargo & Company lifted their target price on shares of Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a research report on Friday, February 28th. Finally, Bank of America boosted their price objective on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $79.86.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.